Symbicort® (budesonide/formoterol) Asthma
This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.
Asthma ICS/LABAs and Symbicort®
Goals of treatment
In the UK, someone is having a potentially life-threatening asthma attack every 10 seconds, and one person is hospitalised every 8 minutes.4
When you prescribe an inhaled corticosteroid (ICS)/long-acting beta agonist (LABA) for an asthma patient with worsening symptoms: